Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older.
- People diagnosed with a specific type of lung cancer (non-squamous) that is locally advanced, classified as stage IIIA, IIIB, or IIIIC according to standard cancer staging guidelines.
- People whose lung cancer tissue analysis shows a mixed cell type (adeno-squamous) or results that are not clearly categorised but lean toward squamous are also considered eligible.
- People who are enrolled and have their first brain MRI scan at around 120 days (plus or minus 10 days) from the start of their radiation therapy for lung cancer — enrolment can happen before or after radiation therapy begins.
- People with a general health and activity level rated between 0 and 3 on a standard medical scale (ranging from fully active to limited self-care; confirm with trial site).
- People whose kidneys are functioning at a sufficient level, as measured by a specific blood test result (confirm with trial site for details).
- People who are safe to undergo a brain MRI scan, as determined by a safety screening checklist completed by relevant medical staff at the trial site.
Who may not be able to join:
- People who already have confirmed cancer that has spread to the brain, as seen on their initial staging MRI scan.
- People who are currently pregnant or breastfeeding.
- People who could potentially become pregnant and do not have a negative pregnancy test taken within 14 days of enrolling in the trial (this requirement does not apply to people who have gone through menopause or have had certain surgeries such as removal of the uterus or ovaries, or have a medically confirmed condition that prevents pregnancy).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Farris, MD, Wake Forest Baptist Comprehensive Cancer Center
Phone: +13367137749
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Central Nervous System Symptoms - Central Nervous System Symptom Scoring Form
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.